Diagnosis and Management of Reactive Arthritis
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 308
Special Issue Editors
Interests: reactive arthritis; spondyloarthritis; classification; health economics
Interests: chlamydia trachomatis; molecular genetics; host–pathogen interactions
Special Issue Information
Dear Colleagues,
Reactive arthritis (ReA) is usually considered part of the spectrum of HLA-B27 spondyloarthritis secondary to a bacterial infection localized in the genitourinary or/and gastrointestinal tract. However, ReA is an extremely heterogeneous disease, with widely varying presentation across the globe that is only in part related to HLA-B27 positivity. Physicians must be aware of the expanding panoply of rare and new pathogens potentially involved in the causation of ReA. Importantly, with the advent of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, an increasing number of cases and case series of acute arthritis following this viral infection have been reported and classified as ReA.
We warmly invite you and your colleagues to submit any types of articles—original research articles, comprehensive and critical reviews, and even letters—to stimulate interest in ReA, discuss the latest research, and develop new ideas and research directions.
Prof. Dr. Henning K. Zeidler
Prof. Dr. Alan P. Hudson
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epidemiology
- classification
- diagnostic criteria
- sexually acquired reactive arthritis
- post-COVID-19 arthritis
- musculoskeletal manifestations
- extra-articular manifestations
- diagnosis
- molecular testing
- imaging diagnostics
- microbiome
- management
- antibiotic therapy
- biologics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
